We aimed to evaluate the effect of multi-ingredient nutritional supplementation, with and without exercise training, on cognitive function in healthy older men. Forty-nine sedentary men (age: 73±6years [mean±SD]; body mass index: 28.5±3.6kg/m2) were randomized to consume a supplement (SUPP n=25; 1500mg n-3 polyunsaturated fatty acids, 30g whey protein, 2.5g creatine, 500IU vitamin D, and 400mg calcium) or control beverage (CON n=24; 22g maltodextrin) twice daily for 20wk consisting of Phase 1: SUPP/CON followed by Phase 2: 12-wk resistance exercise training plus high-intensity interval training, while continuing to consume the study beverages (SUPP/CON+EX). At baseline, 6wk, and 19wk we assessed cognitive function (Montréal Cognitive Assessment [MOCA]), memory (word recall during the Rey Auditory Verbal Learning Test [RAVLT]), and executive functions (working memory inhibition control), and nutrient bioavailability. We did not observe changes to any aspect of cognitive function after Phase 1; however, significant improvements in the following cognitive function outcomes were detected following Phase 2: MOCA scores increased (6wk: 23.5±3.3 vs. 19wk: 24.4±2.5, p=0.013); number of words recalled during the RAVLT (6wk: 6.6±3.6 vs. 19wk: 7.6±3.8, p=0.047); and reaction time improved (6wk: 567±49ms vs. 19wk: 551±51ms, p=0.002). Although between-group differences in these outcomes were not significant, we observed within-group improvements in composite cognitive function scores over the course of the entire study only in the SUPP group (Δ = 0.58±0.62, p=0.004) but not in the CON group (Δ = 0.31±0.61, p=0.06). We observed a progressive increase in n-3 index, and a concomitant decrease in the ratio of arachidonic acid (ARA) to eicosapentaenoic acid (EPA) within erythrocyte plasma membranes, in the SUPP group only. At week 19, n-3 index (r=0.49, p=0.02) and the ARA:EPA ratio (r=-0.44, p=0.03) were significantly correlated with composite cognitive function scores. Our results show that 12 weeks of RET + HIIT resulted in improved MOCA scores, word recall, and reaction time during an executive functions task; and suggest that a multi-ingredient supplement combined with this exercise training program may improve composite cognitive function scores in older men possibly via supplementation-mediated alterations to n-3 PUFA bioavailability. This trial was registered at ClinicalTrials.gov (NCT02281331).
Read Full Article (External Site)
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.